Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00194857 · ClinicalTrials.gov registry record · Phase 4
Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and Ribavirin
A Phase 4 study, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- Phase 4
- Development phase
NCT00194857: Clinical Trial Phase 4 study, sponsored by Weill Medical College of Cornell University.
NCT00194857 is a Phase 4 study that was terminated before completion, run by Weill Medical College of Cornell University. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00194857, a Phase 4 study, was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
Study Summary
This study is designed to test two separate strategies for treatment of anemia (low hemoglobin) and neutropenia (low white blood cells) in HIV/HCV coinfected patients who are being treated with pegylated interferon and ribavirin.
Interventions
- DRUG erythropoietin, GCSF
Trial Details
| Field | Value |
|---|---|
| Start Date | 2002-02 |
| Est. Completion | 2005-12 |
| Phase | Phase 4 |
Why NCT00194857 stopped before completion
NCT00194857 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which erythropoietin, GCSF is the first listed.
NCT00194857 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00194857 about?
NCT00194857 is a clinical study titled "Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and Ribavirin". This study is designed to test two separate strategies for treatment of anemia (low hemoglobin) and neutropenia (low white blood cells) in HIV/HCV coinfected patients who are being treated with pegylated interferon and ribavirin.
What is the current status of trial NCT00194857?
This trial is currently terminated. It is a Phase 4 study. The study started on 2002-02. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00194857?
The interventions under investigation include: erythropoietin, GCSF (DRUG).
Who is sponsoring clinical trial NCT00194857?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia